Key Takeaways
- Margin reset, not a derailment: Consolidated EBITDA margin fell to 11% from 11.4% YoY, driven by a freight reclassification, higher shipping costs, and a planned step-up in brand investment. Management reaffirmed its 13–14% medium-term target.
- Basmati engine still firing: Branded India revenue grew nearly 8% against category growth of ~1.3%, and H1 basmati revenue rose 27% with 11% volume growth, showing strong pricing power even as input costs climb.
- Investment-mode markets are the margin drag: Europe, UK, and the organic business are in build-out phases that are diluting consolidated returns; mature markets like the US and India already operate at 15%+ EBITDA margins.
- Paddy cost headwind is real but manageable: Crop ’26 paddy prices opened 22–25% higher, and management is confident of passing the increase through, citing a long history of doing so with negligible demand impact.
- What to watch next quarter: Whether the Middle East freight mitigation steps actually lift profitability, the pace of price pass-through on the new crop, and any sign that Europe and the organic business are scaling toward their margin targets.
Margin Walk: What Hit Q2
- Gross margin compression: Fell to 32.5% from 34.2% YoY. Two factors: a CIF-to-FOB shipment-term change with a related party that moved freight cost into COGS (EBITDA-neutral reclassification), and higher shipping costs across major markets, with shipping cost as a percentage of revenue rising almost 40 bps.
- Planned brand investment step-up: Advertisement spend jumped ₹25 crores QoQ, a 70 bps increase as a percentage of revenue, to support new launches and brand building. Full-year ad spend target remains 2.3% of revenue, though Q2 reached 2.5%–2.6%.
- Investment ahead of US RTH facility: Spending on the health and convenience portfolio is running ahead of the ready-to-heat facility commissioning in the US, adding to near-term cost.
- Organic business drag easing: Nature Bio Foods EBITDA improved sequentially to ₹22 crores from ₹10 crores in Q1, but the ongoing remodeling from an origin-led ingredient model to a destination-focused food platform continues to suppress revenue and margin.
- H1 consolidated EBITDA margin: 11.2% vs 11.7% in H1 FY26, reflecting higher shipment cost and brand investments up 29% to ₹139 crores.
Sachin Gupta: "We are confident on the margin target 13% to 13.5% to 14% of the EBITDA margin on consolidated basis. It is just investing certain portion of the money in Europe, UK that are diluting my overall EBITDA margin. In the matured markets like US, Europe, or Europe, US, India, we have an EBITDA margin of 15% plus."
Basmati & Specialty Rice: The Core Growth Engine
- H1 revenue up 27% with 11% volume growth: India grew 24% (10% volume), North America grew 21% (13% normalized), and Middle East & rest of world grew 25%. Per-ton realization increased roughly 13%.
- India branded portfolio outperforming: Branded revenue grew nearly 8% against category growth of ~1.3%, supporting a 140 bps market share increase on a YTD basis, driven by premiumization, portfolio expansion, and deeper distribution.
- Pricing power intact: Management sees no demand impact from price increases, noting Basmati is roughly 2% of the total global rice market and that even in the Middle East, where freight costs have spiked above $200, demand has held.
- New crop price pass-through underway: Crop ’26 paddy prices are 22–25% higher on average. In India, a price increase on the new crop has already been given and well accepted; management expects to pass on the higher input cost across markets as the new crop enters production.
- Crop ’25 coverage sufficient: The company is sufficiently covered on crop ’25 inventory to deliver its business plan. Paddy inventory as of September 26 stood at 82,000 tons at ₹43/kg average, with rice inventory at 260,000 tons at ₹60/kg average.
Ashwani Kumar Arora: "We are in this business more than 50 years and we have seen the real test case when this duty came and majority has been passed on and we have not seen any impact on the demand."
Investment-Mode Markets: The Margin Dilution Story
- Middle East: Delivered strong volume growth but the quarter was significantly impacted by supply disruptions that constrained inventory flow and a sharp escalation in freight cost that raised landed cost and weighed heavily on profitability. Mitigation steps (alternate routing, spend optimization, increased pricing) are expected to show full impact in subsequent quarters.
- Europe: Operating environment remains challenging due to raw material and freight cost pressure. The UK was hit by lower-than-planned mainstream and industrial volume and elevated operating costs. The business secured new mainstream private label business across Germany and Nordic markets and strengthened its presence in France, but remains in an investment and scale-building phase.
- UK facility: The facility is part of the strategy as a Basmati company given the UK is a large market. Profitability is expected next year as scale builds.
- Nature Bio Foods: Undergoing a strategic transformation from an India-centric sourcing and export model to a globally integrated, consumer-focused organic food platform. The transition is replacing parts of the traditional intermediary-led business, creating near-term revenue pressure. The new Madhya Pradesh manufacturing facility’s first phase is expected to commence operations this financial year.
Monika Chawla: "Overall, Europe remains in a investment and scale-building phase, but the business today is on a stronger footing than it was few quarters ago."
Health & Convenience: Building the Next Leg
- H1 revenue up 8% YoY to ₹102 crores: Growth came even before enhanced RTH capacity is operational. RTE grew 17%, RTC grew 28%, and RTH grew 7%.
- US ambition: Management aims to leverage its leadership in rice to build a broader branded foods platform in North America, with advanced microwaveable formats and continued premiumization across Royal and Golden Star brands.
- RTH/RTC margin impact: Certain promotions and sampling in H1 FY27 reduced margins as planned, with an overall PBT impact of ₹2 crores increase.
- India health-focused traction: Brown, red, and black rice offerings are seeing encouraging consumer uptake.
Balance Sheet & Working Capital
- Working capital improvement: Inventory days reduced to 159 from 187, trade payable days to 26 from 29, and working capital days to 143 from 174. The company ended H1 FY27 with a net cash position of ₹247 crores.
- Seasonal cash utilization ahead: The net cash position reflects a non-peak procurement period and will be utilized in coming quarters as procurement picks up. Management sees no further scope for working capital improvement from current levels. [16-context]
- European debt reduction: The European business reduced debt by €0.18 crores and improved working capital during H1 FY27.
- Finance cost higher YoY: Driven by higher supplier funding arrangements undertaken to optimize the working capital cycle.
Strategic Priorities & Long-Term Bets
- Five financial priorities: (1) sustaining profitable growth in core basmati and specialty rice, (2) improving profitability in the organic food business, (3) scaling up the convenience food portfolio, (4) driving efficiencies across the value chain, (5) maintaining discipline across working capital and capital allocation.
- Organic business margin target: In the coming two years, management is eyeing the organic business to deliver 10–11% EBITDA margin, up from its current remodeling-phase levels.
- Mature-market basmati margin: In matured markets like the US and India, basmati EBITDA margin is already 15%+. The consolidated margin trajectory from the current 11% toward 13–14% depends on Europe, UK, Middle East, and organic reaching scale.
- Leev investment: Provides entry into the Benelux organic retail market, particularly in breakfast and between-meal snacking.
Monika Chawla: "With branded basmati still significantly underpenetrated in India, we see a long runway to acquire consumers, premiumize the category and expand into adjacent consumption occasions."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Consolidated EBITDA margin | Reach 13% to 13.5% to 14% as investment-mode markets scale | No timeline given (company policy); mature markets already at 15%+ |
| Organic food business EBITDA margin | Deliver 10–11% EBITDA margin | In the coming 2 years |
| Middle East freight mitigation | Full impact of alternate routing, spend optimization, and pricing to show in profitability | Subsequent quarters |
| Crop ’26 paddy cost pass-through | Pass on higher paddy cost to consumers across markets; pricing will reset proportionately | As new crop enters production; India increase already given |
| UK facility profitability | Facility to become profitable | Next year, as scale comes |
| H2 growth momentum | H2 performance to be very similar to H1 | H2 FY27 |
| Ad spend | Remain at 2.3% of revenue on a full-year basis | FY27 |
| Nature Bio Foods Madhya Pradesh facility | First phase to commence operations | This financial year |
| Tariff refund clarity | Resolution expected | By year end |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated revenue | ₹3,253 cr, +17% YoY from ₹2,772 cr and +3% QoQ |
| Gross profit | ₹1,058 cr, +12% YoY from ₹948 cr |
| Gross margin | 32.5%, vs 34.2% in Q2 FY26; freight reclassification and higher shipping costs |
| EBITDA | ₹358 cr, +13% YoY from ₹316 cr, marginally lower than ₹363 cr in Q1 FY27 |
| EBITDA margin | 11.0%, vs 11.4% in Q2 FY26 and 11.5% in Q1 FY27 |
| PAT | ₹180 cr, +10% YoY from ₹164 cr |
| Advertisement spend | 2.5% of revenue, up 70 bps QoQ from 1.8% in Q1 FY27 |
| Basmati and specialty rice volume growth | +11% YoY; value growth +21% YoY |
| Basmati and specialty rice sequential volume growth | +6% QoQ; value growth +5% QoQ |
| India branded portfolio growth | ~8%, vs category growth of ~1.3% |
| Market share gain (India, year-to-date) | +140 bps |
| Household reach (India) | 67.5 lakhs, up from 56.2 lakhs over the last year |
| Organic food segment EBITDA | ₹22 cr, vs ₹10 cr in Q1 FY27 |
| Net cash position | ₹247 cr as of half-year end |
| Return on capital employed | 22.4%, vs 22% last year |
| Inventory days | 159 days, vs 187 days in last half year |
| Working capital days | 143 days, vs 174 days last year |